Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.706,20
-0,81%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Relmada Therapeutics Inc (RLMD) Relmada Therapeutics Inc (RLMD) Notizie

RLMD

Relmada Therapeutics (RLMD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RLMD
DataOraFonteTitoloSimboloCompagnia
08/05/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLMDRelmada Therapeutics Inc
19/03/202412:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:RLMDRelmada Therapeutics Inc
20/02/202423:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
14/02/202414:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RLMDRelmada Therapeutics Inc
01/02/202400:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
11/01/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
21/06/202323:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RLMDRelmada Therapeutics Inc
30/05/202323:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RLMDRelmada Therapeutics Inc
25/05/202322:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RLMDRelmada Therapeutics Inc
12/05/202311:45PR Newswire (US)RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:RLMDRelmada Therapeutics Inc
10/05/202311:45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Relmada Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NYSE: RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
31/03/202315:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RLMDRelmada Therapeutics Inc
14/02/202323:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RLMDRelmada Therapeutics Inc
09/02/202317:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RLMDRelmada Therapeutics Inc
02/02/202323:02Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:RLMDRelmada Therapeutics Inc
08/12/202204:15TipRanksMizuho Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
11/11/202212:55TipRanksRelmada Therapeutics (RLMD) Gets a Buy from Mizuho SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
10/11/202222:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RLMDRelmada Therapeutics Inc
17/10/202206:51TipRanksAnalysts’ Top Healthcare Picks: InMode (INMD), Avidity Biosciences (RNA)NASDAQ:RLMDRelmada Therapeutics Inc
13/10/202218:36TipRanksRelmada Nosedives after Depression Therapy Fails in Phase 3NASDAQ:RLMDRelmada Therapeutics Inc
13/10/202213:45TipRanksMizuho Securities Keeps Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
07/10/202219:55TipRanksRelmada Therapeutics put volume heavy and directionally bearishNASDAQ:RLMDRelmada Therapeutics Inc
16/08/202210:45TipRanksSVB Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
09/08/202215:21Dow Jones NewsRelmada Gets FDA Fast-Track Designation for REL-1017 as MDD MonotherapyNASDAQ:RLMDRelmada Therapeutics Inc
09/05/202202:45TipRanksMizuho Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
08/05/202217:11TipRanksRelmada Therapeutics (RLMD) Gets a Buy Rating from SVB SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
07/04/202223:14Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:RLMDRelmada Therapeutics Inc
29/03/202202:36TipRanksRelmada Therapeutics (RLMD) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
25/03/202212:54Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RLMDRelmada Therapeutics Inc
29/12/202115:36TipRanksAnalysts’ Top Healthcare Picks: LHC Group (LHCG), BridgeBio Pharma (BBIO)NASDAQ:RLMDRelmada Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RLMD

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network